Stoke Therapeutics

Details

  • Unternehmenstyp
    Mittelständisches Unternehmen
About Stoke Therapeutics

Stoke Therapeutics (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. The company utilizes its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach to develop antisense oligonucleotides (ASOs) aimed at selectively restoring naturally-occurring protein levels, with a focus on diseases caused by haploinsufficiency.

Career Opportunities

Stoke Therapeutics offers a dynamic working environment that fosters professional growth and innovation in the biotechnology field. Employees are encouraged to contribute to groundbreaking research and development efforts, making a meaningful impact on patient lives.

  • Collaborative and innovative work culture
  • Opportunities for professional development and advancement
  • Engagement in cutting-edge biotechnology research
>